SSNB in Hemiplegic Shoulder Pain

Stroke Clinical Trial

— SSNB  

Official title:

Suprascapular Nerve Block in Hemiplegic Shoulder Pain.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00732589
• Other study ID #: Chulalongkorn University
• Status: Completed
• Phase: Phase 2
• First received: August 8, 2008
• Last updated: November 17, 2009
• Start date: August 2008
• Est. completion date: May 2009

Study information

• Verified date: August 2008
• Source: Chulalongkorn University
• Contact: n/a
• Is FDA regulated: No
• Health authority: Thailand: Food and Drug Administration
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to compare suprascapular nerve block with therapeutic ultrasound in stroke patients who have shoulder pain in weak side.

Description:

Shoulder pain is a common complication after a cerebrovascular accident.Hemiplegic shoulder pain has been shown to affect stroke outcome in a negative way.It interferes with recovery after stroke:it can cause distress and reduced activities and can markedly hinder rehabilitation.Suprascapular nerve block has been shown to be effective as an analgesic for different indications such as shoulder capsulitis.The purpose of this study was to evaluate the effectiveness of this technique conjunction with a rehabilitation program to reduce shoulder pain in hemiplegic patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 0
• Est. completion date: May 2009
• Est. primary completion date: December 2008
• Accepts healthy volunteers: No
• Gender: Female
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Stroke patients who develope shoulder pain at weak limb.

• Good conscious and able to access pain score.

• No history of drug reaction with xylocaine

• No history of fracture,tumor or blood tendency.

• Willing to enrolled to study and signs inform consent.

Exclusion Criteria:

• Patients who do not meet the inclusion criteria.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Shoulder Pain
• Stroke

Intervention

Drug:
• 1% xylocaine
10 cc. of 1%xylocaine, once a week

Other:
• ultrasound
ultrasound at shoulder area about 10 mins.

Locations

Country	Name	City	State
Thailand	Department of physical medicine and rehabilitation, Faculty of medicien, Chulalongkorn University	Bangkok

Sponsors (1)

Lead Sponsor	Collaborator
Chulalongkorn University

Country where clinical trial is conducted

Thailand, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	VAS score of pain		4 weeks after intervention	No
Secondary	Range of motion of the shoulder joint		4 weeks after intervention	No